| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |